59,303 Shares in Capricor Therapeutics Inc (NASDAQ:CAPR) Purchased by Marshall Wace LLP
Marshall Wace LLP bought a new stake in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 59,303 shares of the biotechnology company’s stock, valued at approximately $818,000. Marshall Wace LLP owned […]
Marshall Wace LLP bought a new stake in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 59,303 shares of the biotechnology company’s stock, valued at approximately $818,000. Marshall Wace LLP owned […]
